Histoplasmosis classification: Difference between revisions
No edit summary |
|||
Line 13: | Line 13: | ||
*1. '''Pulmonary histoplasmosis''' | *1. '''Pulmonary histoplasmosis''' | ||
:*This may manifest in the following forms: | :*This may manifest in the following forms: | ||
:** | :**Acute pulmonary [[histoplasmosis]] | ||
:** | :**Chronic cavitary pulmonary [[histoplasmosis]] | ||
:**Broncholithiasis | :**Broncholithiasis | ||
:**Pulmonary nodules (Histoplasmomas) | :**Pulmonary nodules (Histoplasmomas) | ||
Line 26: | Line 26: | ||
*5. '''Mediastinal histoplasmosis''' | *5. '''Mediastinal histoplasmosis''' | ||
:*This may manifest in the following forms: | :*This may manifest in the following forms: | ||
:**[[Mediastinal]] [[lymphadenitis]] | :**[[Mediastinal]] [[lymphadenitis]] | ||
:**[[Mediastinal]] [[granuloma]] | :**[[Mediastinal]] [[granuloma]] | ||
:**[[Mediastinal]] | :**[[Mediastinal fibrosis]] | ||
===B. Severity of disease=== | ===B. Severity of disease=== | ||
On the basis of disease severity, histoplasmosis may be as follows: | On the basis of disease severity, histoplasmosis may be as follows: | ||
{| style="border: 0px; font-size: 90%; margin: 3px;" align=center | {| style="border: 0px; font-size: 90%; margin: 3px;" align="center" | ||
|+ | |+ | ||
|- | |- | ||
Line 39: | Line 39: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC;" |Mild | | style="padding: 5px 5px; background: #DCDCDC;" |Mild | ||
| style="padding: 5px 5px; background: #F5F5F5; | | colspan="2" style="padding: 5px 5px; background: #F5F5F5;" | | ||
*Early diagnosis and treatment | *Early diagnosis and treatment | ||
*Responds to medical treatment | *Responds to medical treatment | ||
Line 46: | Line 46: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC;" |Moderate | | style="padding: 5px 5px; background: #DCDCDC;" |Moderate | ||
| style="padding: 5px 5px; background: #F5F5F5; | | colspan="2" style="padding: 5px 5px; background: #F5F5F5;" | | ||
*May present late with typical or atypical symptoms | *May present late with typical or atypical symptoms | ||
*May present with complications | *May present with complications | ||
Line 52: | Line 52: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC;" |Severe | | style="padding: 5px 5px; background: #DCDCDC;" |Severe | ||
| style="padding: 5px 5px; background: #F5F5F5; | | colspan="2" style="padding: 5px 5px; background: #F5F5F5;" | | ||
*Presents with complications or prolonged illness | *Presents with complications or prolonged illness | ||
*[[Immunocompromised]] | *[[Immunocompromised]] | ||
Line 64: | Line 64: | ||
===C. According to the duration of disease=== | ===C. According to the duration of disease=== | ||
{| style="border: 0px; font-size: 90%; margin: 3px;" align=center | {| style="border: 0px; font-size: 90%; margin: 3px;" align="center" | ||
|+ | |+ | ||
|- | |- | ||
Line 70: | Line 70: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC;" |Acute | | style="padding: 5px 5px; background: #DCDCDC;" |Acute | ||
| style="padding: 5px 5px; background: #F5F5F5; | | colspan="2" style="padding: 5px 5px; background: #F5F5F5;" | | ||
* Lasts few weeks | * Lasts few weeks | ||
* Patient acutely ill | * Patient acutely ill | ||
Line 78: | Line 78: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC;" |Subacute | | style="padding: 5px 5px; background: #DCDCDC;" |Subacute | ||
| style="padding: 5px 5px; background: #F5F5F5; | | colspan="2" style="padding: 5px 5px; background: #F5F5F5;" | | ||
* Lasts less than 4 weeks | * Lasts less than 4 weeks | ||
* Patient acutely ill | * Patient acutely ill | ||
Line 86: | Line 86: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC;" |Chronic | | style="padding: 5px 5px; background: #DCDCDC;" |Chronic | ||
| style="padding: 5px 5px; background: #F5F5F5; | | colspan="2" style="padding: 5px 5px; background: #F5F5F5;" | | ||
* Lasts more than 4 weeks | * Lasts more than 4 weeks | ||
* Gradual deterioration of patient | * Gradual deterioration of patient | ||
Line 93: | Line 93: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC;" |Recurrent | | style="padding: 5px 5px; background: #DCDCDC;" |Recurrent | ||
| style="padding: 5px 5px; background: #F5F5F5; | | colspan="2" style="padding: 5px 5px; background: #F5F5F5;" | | ||
* Multiple episodes which lasts less than 4 weeks | * Multiple episodes which lasts less than 4 weeks | ||
* History of incompliance to medication | * History of incompliance to medication | ||
Line 99: | Line 99: | ||
|- | |- | ||
|} | |} | ||
===D. Progression of disease=== | ===D. Progression of disease=== |
Revision as of 20:55, 14 June 2017
Histoplasmosis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Histoplasmosis classification On the Web |
American Roentgen Ray Society Images of Histoplasmosis classification |
Risk calculators and risk factors for Histoplasmosis classification |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Prince Tano Djan, BSc, MBChB [2], Usama Talib, BSc, MD [3], Aravind Kuchkuntla, M.B.B.S[4]
Overview
Histoplasmosis can be classified with respect to the involved organ system. This can include pulmonary, nervous system, cardiovascular system and mediastinum. Histoplasmosis can also be classified according to the severity in to mild, moderate and severe, according to disease duration into acute, subacute, chronic and recurrent and according to the progression of the disease into localized or disseminated histoplasmosis.[1][2]
Classification
A. Organ system classification
- 1. Pulmonary histoplasmosis
- This may manifest in the following forms:
- Acute pulmonary histoplasmosis
- Chronic cavitary pulmonary histoplasmosis
- Broncholithiasis
- Pulmonary nodules (Histoplasmomas)
- This may manifest in the following forms:
- 2. CNS histoplasmosis
- 3. Histoplasma pericarditis
- 4. Rheumatologic histoplasmosis
- 5. Mediastinal histoplasmosis
- This may manifest in the following forms:
B. Severity of disease
On the basis of disease severity, histoplasmosis may be as follows:
According to severity of the disease | ||
Mild |
| |
Moderate |
| |
Severe |
|
C. According to the duration of disease
According to the duration of disease | |||
Acute |
| ||
Subacute |
| ||
Chronic |
| ||
Recurrent |
|
D. Progression of disease
- Localised histoplasmosis
- Disseminated histoplasmosis
References
- ↑ Untanu RV, Akbar S, Graziano S, Vajpayee N (2016). "Histoplasmosis-Induced Hemophagocytic Lymphohistiocytosis in an Adult Patient: A Case Report and Review of the Literature". Case Rep Infect Dis. 2016: 1358742. doi:10.1155/2016/1358742. PMC 5088313. PMID 27830097.
- ↑ Wheat LJ, Azar MM, Bahr NC, Spec A, Relich RF, Hage C (2016). "Histoplasmosis". Infect Dis Clin North Am. 30 (1): 207–27. doi:10.1016/j.idc.2015.10.009. PMID 26897068.